Updated: 10/16/2019

Colorectal Cancer

Topic
Review Topic
0
0
Questions
6
0
0
Evidence
4
0
0
Snapshot
  • A 66-year-old man presents to his primary care physician for a routine exam. He reports a change in his bowel habits and noticed his stool is pencil thin. He also endorses an unintentional 15-pound weight loss over the course of 1 month. His father died of colon cancer when he was 65 years of age. Physical examination is notable for tenderness upon palpation in the left abdomen. Colonoscopy is notable for a colonic mass in the descending colon.
Introduction
  • Overview
    • describes malignancy affecting the colon or rectum 
    • most colorectal cancer arises from an adenomatous polyp
  • Epidemiology
    • incidence
      • incidence has decreased due to improved screening practices (e.g., colonoscopy)
    • demographics
      • typically seen in ≥ 60 years of age
      • men > women
    • risk factors
      • hereditary syndromes
        • Lynch syndrome (hereditary nonpolyposis colorectal cancer)
        • familial adenomatous polyposis
        • MYH-associated polyposis
      • environmental factors
        • diets high in animal fat
      • inflammatory bowel disease
        • ulcerative colitis
        • Crohn disease
      • cigarette smoking
  • Pathogenesis
    • chromosomal instability pathway
      • APC/β-catenin gene mutation
        • initiating event in adenoma formation
        • leads to the formation of an aberrant crypt foci
      • KRAS mutation
        • leads to unregulating intracellular signaling resulting in adenoma formation
      • p53 and DCC gene mutation
        • results in tumorgenesis and invasive cancer
    • microsatellite instability pathway
      • mismatch repair genes
        • abnormal methylation or mutations leads to cancer development in patients with Lynch syndrome and certain sporadic colorectal cancers
  • Associated conditions
    • Streptococcus gallolyticus (previously known as Streptococcus bovis)
      • although rare, can present with this bacteremia
Presentation
  • Clinical presentation depends on the location of the colorectal cancer
  • Symptoms/physical exam
    • asymptomatic
      • these patients can be found to have colorectal cancer upon routine screening
    • change in bowel habits
      • typically seen in cancer affecting the descending colon
    • rectal bleeding
      • typically seen in rectal cancers
    • rectal or abdominal mass
    • unexplained iron deficiency anemia 
      • secondary to gastrointestinal bleeding
      • typically seen in cancer affecting the ascending colon
    • malaise, unintentional weight-loss, and fatigue
Imaging
  • Colonoscopy
    • indication
      • to visualize the colonic mucosa and obtain a biopsy from colonic mass to establish a histologic diagnosis
      • gold standard for evaluating for colorectal cancer
      • screening method
        • low-risk patients
          • screen at 50 years of age
            • continue performing every 10 years
        • first-degree relative with colon cancer
          • screen at 40 years of age or 10 years prior to the relatives age of presentation 
        • for patients who do not want to undergo colonoscopy, other screening options include
          • fecal immunochemical test (FIT)
            • assesses for ocult blood in the stool
          • computed tomography colonography
Differential
  • Diverticulitis
    • differentiating factors
      • inflammation of the diverticula
Treatment
  • Treatment is geared towards the staging of the malignacy
  • Surgical
    • resection
      • indication
        • performed in localized disease
          • typically given with adjuvant chemotherapy
Complications
  • Colonic obstrucition
  • Bowel perforation
  • Metastasis
 

Please rate topic.

Average 4.8 of 4 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (6)
Lab Values
Blood, Plasma, Serum Reference Range
ALT 8-20 U/L
Amylase, serum 25-125 U/L
AST 8-20 U/L
Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL
Calcium, serum (Ca2+) 8.4-10.2 mg/dL
Cholesterol, serum Rec: < 200 mg/dL
Cortisol, serum 0800 h: 5-23 μg/dL //1600 h:
3-15 μg/dL
2000 h: ≤ 50% of 0800 h
Creatine kinase, serum Male: 25-90 U/L
Female: 10-70 U/L
Creatinine, serum 0.6-1.2 mg/dL
Electrolytes, serum  
Sodium (Na+) 136-145 mEq/L
Chloride (Cl-) 95-105 mEq/L
Potassium (K+) 3.5-5.0 mEq/L
Bicarbonate (HCO3-) 22-28 mEq/L
Magnesium (Mg2+) 1.5-2.0 mEq/L
Estriol, total, serum (in pregnancy)  
24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL
28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL
Ferritin, serum Male: 15-200 ng/mL
Female: 12-150 ng/mL
Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL
Female: premenopause: 4-30 mIU/mL
midcycle peak: 10-90 mIU/mL
postmenopause: 40-250
pH 7.35-7.45
PCO2 33-45 mmHg
PO2 75-105 mmHg
Glucose, serum Fasting: 70-110 mg/dL
2-h postprandial:<120 mg/dL
Growth hormone - arginine stimulation Fasting: <5 ng/mL
Provocative stimuli: > 7ng/mL
Immunoglobulins, serum  
IgA 76-390 mg/dL
IgE 0-380 IU/mL
IgG 650-1500 mg/dL
IgM 40-345 mg/dL
Iron 50-170 μg/dL
Lactate dehydrogenase, serum 45-90 U/L
Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL
Female: follicular phase: 5-30 mIU/mL
midcycle: 75-150 mIU/mL
postmenopause 30-200 mIU/mL
Osmolality, serum 275-295 mOsmol/kd H2O
Parathyroid hormone, serume, N-terminal 230-630 pg/mL
Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L
Phosphorus (inorganic), serum 3.0-4.5 mg/dL
Prolactin, serum (hPRL) < 20 ng/mL
Proteins, serum  
Total (recumbent) 6.0-7.8 g/dL
Albumin 3.5-5.5 g/dL
Globulin 2.3-3.5 g/dL
Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL
Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h
Thyroxine (T4), serum 5-12 μg/dL
Triglycerides, serum 35-160 mg/dL
Triiodothyronine (T3), serum (RIA) 115-190 ng/dL
Triiodothyronine (T3) resin uptake 25%-35%
Urea nitrogen, serum 7-18 mg/dL
Uric acid, serum 3.0-8.2 mg/dL
Hematologic Reference Range
Bleeding time 2-7 minutes
Erythrocyte count Male: 4.3-5.9 million/mm3
Female: 3.5-5.5 million mm3
Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/h
Female: 0-20 mm/h
Hematocrit Male: 41%-53%
Female: 36%-46%
Hemoglobin A1c ≤ 6 %
Hemoglobin, blood Male: 13.5-17.5 g/dL
Female: 12.0-16.0 g/dL
Hemoglobin, plasma 1-4 mg/dL
Leukocyte count and differential  
Leukocyte count 4,500-11,000/mm3
Segmented neutrophils 54%-62%
Bands 3%-5%
Eosinophils 1%-3%
Basophils 0%-0.75%
Lymphocytes 25%-33%
Monocytes 3%-7%
Mean corpuscular hemoglobin 25.4-34.6 pg/cell
Mean corpuscular hemoglobin concentration 31%-36% Hb/cell
Mean corpuscular volume 80-100 μm3
Partial thromboplastin time (activated) 25-40 seconds
Platelet count 150,000-400,000/mm3
Prothrombin time 11-15 seconds
Reticulocyte count 0.5%-1.5% of red cells
Thrombin time < 2 seconds deviation from control
Volume  
Plasma Male: 25-43 mL/kg
Female: 28-45 mL/kg
Red cell Male: 20-36 mL/kg
Female: 19-31 mL/kg
Cerebrospinal Fluid Reference Range
Cell count 0-5/mm3
Chloride 118-132 mEq/L
Gamma globulin 3%-12% total proteins
Glucose 40-70 mg/dL
Pressure 70-180 mm H2O
Proteins, total < 40 mg/dL
Sweat Reference Range
Chloride 0-35 mmol/L
Urine  
Calcium 100-300 mg/24 h
Chloride Varies with intake
Creatinine clearance Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)  
30 wks 6-18 mg/24 h
35 wks 9-28 mg/24 h
40 wks 13-42 mg/24 h
17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 h
Female: 2.0-8.0 mg/24 h
17-Ketosteroids, total Male: 8-20 mg/24 h
Female: 6-15 mg/24 h
Osmolality 50-1400 mOsmol/kg H2O
Oxalate 8-40 μg/mL
Potassium Varies with diet
Proteins, total < 150 mg/24 h
Sodium Varies with diet
Uric acid Varies with diet
Body Mass Index (BMI) Adult: 19-25 kg/m2
Calculator

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
ARTICLES (5)
Topic COMMENTS (20)
Private Note